Cancer BiologybioRxivPreprint
PCSK9 dependent cholesterol acquisition and utilization underlies metastatic organ preference in pancreatic cancer.
Gilles Rademaker, Grace A. Hernandez, Sumena Dahal…·Rushika M. Perera
This study identifies PCSK9 as a key determinant of metastatic organ preference in pancreatic cancer by regulating cholesterol acquisition and utilization in liver versus lung environments.
DOI 10.1101/2025.04.22.649912